Rilpivirine Disease Interactions
There are 3 disease interactions with rilpivirine.
Rilpivirine (applies to rilpivirine) depression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Psychosis
Depressive symptoms including suicide ideation and suicide attempts have been reported with the use of rilpivirine. Patients should be monitored for the appearance of these symptoms and should seek medical evaluation immediately if severe depressive symptoms occur. Caution should be used in patients with a history of depression or other psychiatric conditions.
References
- (2011) "Product Information. Edurant (rilpivirine)." Tibotec Pharmaceuticals
Rilpivirine (applies to rilpivirine) liver impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Hepatic adverse events have been reported in patients taking rilpivirine. Patients with underlying hepatitis B or C virus infection or marked transaminase elevations prior to therapy may be at increased risk for worsening or development of transaminase elevations; a few cases of hepatic toxicity have been reported in patients without preexisting hepatic disease or other known risk factors. Appropriate laboratory testing before starting therapy and monitoring for hepatotoxicity during therapy are recommended in patients with underlying hepatic disease (e.g., hepatitis B or C virus infection) or in patients with marked baseline transaminase elevations. Rilpivirine has not been studied in patients with severe liver dysfunction (Child-Pugh C); caution is recommended.
References
- (2011) "Product Information. Edurant (rilpivirine)." Tibotec Pharmaceuticals
Rilpivirine (applies to rilpivirine) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Rilpivirine should be used with caution and with increased monitoring for side effects in patients with severe renal dysfunction or end-stage renal disease, as drug concentrations can be increased due to alteration of drug absorption, distribution, and metabolism secondary to renal dysfunction. No dose adjustment is required in patients with mild or moderate renal dysfunction.
References
- (2011) "Product Information. Edurant (rilpivirine)." Tibotec Pharmaceuticals
Rilpivirine drug interactions
There are 399 drug interactions with rilpivirine.
Rilpivirine alcohol/food interactions
There is 1 alcohol/food interaction with rilpivirine.
More about rilpivirine
- rilpivirine consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.